LTR Pharma Limited (ASX:LTP)
Australia
· Delayed Price · Currency is AUD 0.450
0.00 (0.00%)
At close: Mar 6, 2026
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 81.80 million as of March 6, 2026. Its market cap has decreased by -28.26% in one year.
Market Cap
81.80M
Enterprise Value
56.02M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.45
Market Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 81.80M, an increase of 54.40%. That is a compound annual growth rate of 21.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 81.80M | -37.45% |
| Dec 31, 2025 | 130.78M | -10.78% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cynata Therapeutics | 81.92M |
| Imugene | 77.16M |
| Alterity Therapeutics | 76.13M |
| Radiopharm Theranostics | 74.43M |
| Arovella Therapeutics | 96.57M |
| Prescient Therapeutics | 62.04M |
| Paradigm Biopharmaceuticals | 112.01M |
| Neurizon Therapeutics | 57.16M |